Federica Ravera

469 total citations
16 papers, 343 citations indexed

About

Federica Ravera is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Federica Ravera has authored 16 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Federica Ravera's work include Glycosylation and Glycoproteins Research (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and Metabolism and Genetic Disorders (2 papers). Federica Ravera is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and Metabolism and Genetic Disorders (2 papers). Federica Ravera collaborates with scholars based in Italy, France and Israel. Federica Ravera's co-authors include Paolo Esposto Pirani, Roberto E. Favoni, Marialuisa Querques, Douglas M. Noonan, Antonella Radice, G Ortisi, Giampaola Pesce, Barbara Trezzi, Giacomo Colussi and Marco DʼAmico and has published in prestigious journals such as International Journal of Cancer, European Journal of Pharmacology and European Journal of Cancer.

In The Last Decade

Federica Ravera

16 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Ravera Italy 10 162 104 96 95 85 16 343
Christos Bantis Germany 13 214 1.3× 45 0.4× 56 0.6× 71 0.7× 44 0.5× 21 397
Takashi Ando Japan 11 387 2.4× 111 1.1× 107 1.1× 73 0.8× 16 0.2× 19 502
Miltiadis Gerolymos Greece 8 72 0.4× 25 0.2× 50 0.5× 43 0.5× 38 0.4× 11 333
Kan Katayama Japan 12 173 1.1× 32 0.3× 162 1.7× 71 0.7× 24 0.3× 52 461
Hidehisa Kitada Japan 13 66 0.4× 27 0.3× 60 0.6× 38 0.4× 29 0.3× 39 324
M Ueno Japan 11 137 0.8× 28 0.3× 106 1.1× 34 0.4× 23 0.3× 24 319
Mitsuo lida Japan 9 51 0.3× 131 1.3× 134 1.4× 53 0.6× 34 0.4× 13 370
S Costantini Italy 9 56 0.3× 144 1.4× 49 0.5× 59 0.6× 14 0.2× 19 379
Dhruti P. Chen United States 6 190 1.2× 34 0.3× 88 0.9× 71 0.7× 15 0.2× 11 361
Christian Hanna United States 9 78 0.5× 60 0.6× 91 0.9× 80 0.8× 16 0.2× 30 330

Countries citing papers authored by Federica Ravera

Since Specialization
Citations

This map shows the geographic impact of Federica Ravera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Ravera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Ravera more than expected).

Fields of papers citing papers by Federica Ravera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Ravera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Ravera. The network helps show where Federica Ravera may publish in the future.

Co-authorship network of co-authors of Federica Ravera

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Ravera. A scholar is included among the top collaborators of Federica Ravera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Ravera. Federica Ravera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Colussi, Giacomo, et al.. (2022). End-proximal tubule phosphate concentration increases as GFR falls in humans: measurement by means of a lithium clearance-based methodology. Nephrology Dialysis Transplantation. 38(3). 671–678. 1 indexed citations
3.
Radice, Antonella, Federico Pieruzzi, Barbara Trezzi, et al.. (2017). Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Journal of Nephrology. 31(2). 271–278. 55 indexed citations
4.
Ravera, Federica, et al.. (2017). [Immunosuppression in kidney transplantation: a way between efficacy and toxicity].. PubMed. 34(2). 29–39. 5 indexed citations
5.
Bencardino, Katia, Gianluca Mauri, Alessio Amatu, et al.. (2016). Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study. Clinical Colorectal Cancer. 15(3). 213–221. 26 indexed citations
6.
Radice, Antonella, Barbara Trezzi, Umberto Maggiore, et al.. (2015). Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Autoimmunity Reviews. 15(2). 146–154. 75 indexed citations
7.
Colussi, Giacomo, Liat Ganon, Silvana Penco, et al.. (2013). Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure. Nephrology Dialysis Transplantation. 29(3). 636–643. 43 indexed citations
8.
Bonucchi, Decenzio, et al.. (2010). ["Terzo fuoco", lead poisoning and chronic renal failure].. PubMed. 24 Suppl 38. 76–9. 2 indexed citations
9.
Guaraldi, Giovanni, Alberto Roverato, C. Giovanardi, et al.. (2008). Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. Journal of Antimicrobial Chemotherapy. 63(2). 374–379. 11 indexed citations
10.
Cappelli, Gianni, Marco Ricardi, Federica Ravera, et al.. (2006). Biofilm on Artificial Surfaces. Contributions to nephrology. 154. 61–71. 4 indexed citations
11.
Cappelli, Gianni, Federica Ravera, Marco Ricardi, et al.. (2005). Water Treatment for Hemodialysis: A 2005 Update. Contributions to nephrology. 149. 42–50. 9 indexed citations
12.
Sofia, A., Rodolfo Russo, Stefano Saffioti, et al.. (2002). [Acute effects of peritoneal dialysis on muscle protein turnover].. PubMed. 19(1). 37–43. 1 indexed citations
13.
Favoni, Roberto E., Alessandra de Cupis, Federica Ravera, et al.. (1994). Expression and function of the insulin‐like growth factor I system in human non‐small‐cell lung cancer and normal lung cell lines. International Journal of Cancer. 56(6). 858–866. 52 indexed citations
14.
Favoni, Roberto E., Federica Ravera, Paolo Esposto Pirani, et al.. (1994). Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines. European Journal of Pharmacology. 264(2). 199–206. 7 indexed citations
15.
Ravera, Federica, Loredana Miglietta, Paolo Esposto Pirani, Silvano Ferrini, & Roberto E. Favoni. (1993). Suramin-induced growth inhibition and insulinlike growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events. European Journal of Cancer. 29(2). 225–230. 21 indexed citations
16.
Marugo, M, D. Bernasconi, Loredana Miglietta, et al.. (1992). Effects of dihydrotestosterone and hydroxyflutamide on androgen receptors in cultured human breast cancer cells (EVSA-T). The Journal of Steroid Biochemistry and Molecular Biology. 42(5). 547–554. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026